サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1280706

細胞単離/細胞分離の世界市場：製品種類別 (消耗品、装置)・細胞の種類別 (ヒト細胞、動物細胞)・細胞の供給源別 (骨髄、細胞組織)・技術別 (遠心分離式)・用途別・エンドユーザー別 (製薬企業) の将来予測 (2028年まで)

Cell Isolation/ Cell Separation Market by Product (Consumables, Instruments), Cell Type (Human Cells, Animal Cells), Cell Source (Bone Marrow, Adipose Tissues), Technique (Centrifugation-based), Application, End User (Pharma) - Global Forecast to 2028
出版日: | 発行: MarketsandMarkets | ページ情報: 英文 309 Pages | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
細胞単離/細胞分離の世界市場：製品種類別 (消耗品、装置)・細胞の種類別 (ヒト細胞、動物細胞)・細胞の供給源別 (骨髄、細胞組織)・技術別 (遠心分離式)・用途別・エンドユーザー別 (製薬企業) の将来予測 (2028年まで)
出版日: 2023年05月19日
発行: MarketsandMarkets
ページ情報: 英文 309 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界の細胞単離の市場規模は、2023年の44億米ドルから、2028年には82億米ドルに達すると予測され、予測期間中のCAGRは13.4%と見込まれています。

細胞ベースの研究に対する資金提供の増加などの要因が、市場の成長を加速させています。慢性疾患や感染症の発生率は増加傾向にあり、細胞単離技術を必要とする細胞ベースの治療法などの新しい治療法への需要が高まっています。マイクロ流体ベースのセルソーティング、磁気活性化細胞分ぺつ、蛍光活性化細胞分別など、新しく高度な細胞単離技術の開拓が、市場の成長を後押ししています。また、政府や民間団体がライフサイエンスやバイオテクノロジー研究に多額の投資を行っており、これが細胞単離製品・技術の需要を促進しています。

"消耗品セグメントは、予測期間中 (2023年～2028年) に最も高いCAGRで成長する"

製品別では、消耗品セグメントが予測期間中に最も高いCAGRで成長すると予測されています。この成長は、細胞ベースの研究における消耗品の需要増に起因しています。これは、セグメントの成長に好影響を与えると思われます。消耗品は、手作業による細胞単離手順の必要性を減らすことで、時間を節約することができます。これは、臨床現場など、時間が非常に重要な活用領域で特に重要です。様々な実験条件や細胞種に対応できるため、研究者のニーズに合わせてプロトコルをカスタマイズすることができます。消耗品は、分離プロセスにおける汚染のリスクを低減することができ、分離された細胞の完全性を維持するために重要です。消耗品は、遺伝子発現解析やプロテオミクスなど、下流の様々な活用領域に適合するように設計されていることが多いです。

"ヒト細胞分野が、2023年に圧倒的なシェアを占める"

ヒト細胞に関する研究への投資が増加していることから、予測期間中はヒト細胞セグメントが圧倒的なシェアを占めると予想されます。HeLa細胞などのヒト細胞株は、数十年にわたって研究に使用されており、医学研究の多くの分野で重要なツールとなっています。確立された細胞株が利用できるようになったことで、研究者はヒト細胞を入手し、研究することが容易になりました。研究においてヒト細胞を使用することで、ヒトの生理や病気をより正確に表現することができるため、研究室から臨床への研究成果の伝達を促進することができます。研究においてヒト細胞を使用することは、動物細胞を使用するよりも一般的に受け入れられやすいです。なぜなら、ヒト細胞はより関連性が高く、論争も少ないと考えられるからです。

"骨髄セグメントは、予測期間中 (2023年～2028年) に最も高いCAGRで成長する"

細胞供給源別では、骨髄セグメントが予測期間中に最も高いCAGRで成長すると予測されています。骨髄には、造血幹細胞、間葉系幹細胞、免疫細胞など、多様な細胞集団が存在するため、様々な治療用途で骨髄由来の幹細胞ベースの製品が商業化されていることが、成長の要因となっています。これらの細胞は単離され、研究、創薬、細胞ベースの治療など、幅広い用途に使用することができます。骨髄細胞の分離は、長年にわたり確立され、標準化されてきたため、研究者は高品質の細胞を容易に入手することができます。

"表面マーカー式細胞単離のセグメントは、予測期間中 (2023年～2028年) に最も高いCAGRで成長する"

技術別では、表面マーカー式細胞単離が予測期間中に最も高いCAGRで成長すると予測されています。この成長は、製薬業界におけるこの技術の需要の増加に起因しています。これは、セグメント別の成長を促進すると思われます。

"2022年に、生体分子分離セグメントが圧倒的なシェアを占めた"

用途別では、生体分子単離のセグメントが圧倒的なシェアを占めています。

"製薬企業・バイオテクノロジー企業のセグメントが、予測期間中 (2023年～2028年) に最も高いCAGRで成長する"

エンドユーザー別では、予測期間中に、製薬企業・バイオテクノロジー企業セグメントが最も高いCAGRで成長すると考えられます。製薬企業やバイオテクノロジー企業が研究開発活動に注力していることが、市場成長を予測する主要因の1つとなっています。

"アジア太平洋地域は、より速いペースで成長する"

2022年に、北米は細胞単離市場で圧倒的なシェアを占めています。同地域の優位性は、同地域における支配的かつ巨大な企業の存在、技術進歩など、さまざまな要因に起因しています。アジア太平洋地域は、人口の増加や医療施設のインフラ整備に対する政府の取り組みなど、さまざまな要因によって、より速いペースで成長すると考えられます。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • イントロダクション
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
    • 課題
  • 顧客のビジネスに影響を与える動向/混乱
  • 価格分析
  • バリューチェーン分析
  • エコシステム分析
  • 規制分析
  • ポーターのファイブフォース分析
  • 主な会議とイベント (2023年～2024年)
  • 技術分析
  • 主要な利害関係者と購入基準
  • 貿易分析
  • 特許分析

第6章 細胞単離市場：製品別

  • イントロダクション
  • 消耗品
    • 試薬、キット、培地、血清
    • ビーズ
    • 使い捨て用品
  • 装置
    • 遠心分離機
    • セルソーター
    • 磁気活性化細胞分別システム
    • 濾過システム

第7章 細胞単離市場：細胞の種類別

  • イントロダクション
  • ヒト細胞
    • 分化細胞
    • 幹細胞
  • 動物細胞

第8章 細胞単離市場：細胞の供給源別

  • イントロダクション
  • 骨髄
  • 脂肪組織
  • 臍帯血/胚性幹細胞
  • その他の細胞の供給源

第9章 細胞単離市場：技術別

  • イントロダクション
  • 遠心分離式細胞単離
  • 表面マーカー式細胞単離
  • 濾過式細胞単離

第10章 細胞単離市場：用途別

  • イントロダクション
  • 生体分子の分離
  • がん研究
  • 幹細胞研究
  • 組織再生と再生医療
  • 体外診断
  • その他の用途

第11章 細胞単離市場：エンドユーザー別

  • イントロダクション
  • 製薬企業・バイオテクノロジー企業
  • 学術・研究機関
  • 病院と診断検査室
  • その他のエンドユーザー

第12章 細胞単離市場：地域別

  • イントロダクション
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他の欧州
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • オーストラリア
    • その他のアジア太平洋
  • ラテンアメリカ
    • ブラジル
    • その他のラテンアメリカ
  • 中東・アフリカ

第13章 競合情勢

  • イントロダクション
  • 主要企業が採用した戦略
  • 市場シェア分析
  • 収益分析
  • 企業評価マトリックス
  • 上位25社の競合ベンチマーキング
  • スタートアップ/中小企業向け企業評価マトリックス
  • 競合シナリオと動向

第14章 企業プロファイル

  • 主要企業
    • THERMO FISHER SCIENTIFIC, INC.
    • BECTON, DICKINSON AND COMPANY (BD)
    • DANAHER CORPORATION
    • MERCK KGAA
    • TERUMO CORPORATION
    • AGILENT TECHNOLOGIES, INC.
    • BIO-RAD LABORATORIES, INC.
    • CORNING INCORPORATED
    • F. HOFFMANN-LA ROCHE LTD.
    • ALFA LAVAL
    • MILTENYI BIOTEC
    • SARTORIUS AG
    • STEMCELL TECHNOLOGIES
    • AKADEUM LIFE SCIENCES
    • BIO-TECHNE
  • その他の企業
    • TAKARA BIO INC.
    • QIAGEN
    • LONZA GROUP
    • PERKINELMER INC. (BIOLEGEND, INC.)
    • PROMEGA CORPORATION
    • PROTEINTECH GROUP, INC.
    • PLURISELECT LIFE SCIENCE UG (HAFTUNGSBESCHRANKT) & CO. KG
    • INVENT BIOTECHNOLOGIES, INC.
    • MICAREO INC.
    • MAGBIO GENOMICS

第15章 付録

目次
Product Code: BT 2757

The global cell isolation market size is projected to reach USD 8.2 billion by 2028 from USD 4.4 billion in 2023, at a CAGR of 13.4% during the forecast period. Factors such as increasing funding for cell-based research, are driving the market growth at a faster pace. The incidence of chronic and infectious diseases is on the rise, which is driving the demand for new therapies, including cell-based therapies that require cell isolation technologies. The development of new and advanced cell isolation technologies, such as microfluidics-based cell sorting, magnetic-activated cell sorting, and fluorescence-activated cell sorting, is driving the growth of the market. Governments and private organizations are investing heavily in life sciences and biotechnology research, which is driving the demand for cell isolation products and technologies.

"The consumables segment is likely to grow at highest CAGR during the forecast period of 2023-2028."

On the basis of product, the cell isolation market is segmented into consumables and instruments. The consumables segment is projected to grow at the highest CAGR during the forecast period. The growth is attributed to increasing demand of consumables in cell based research. This is likely to have a positive impact on segmental growth. Consumables can save time by reducing the need for manual cell isolation procedures. This can be especially important for applications where time is critical, such as in clinical settings. Consumables can be adapted to different experimental conditions and cell types, allowing researchers to customize their protocols to their specific needs. Consumables can reduce the risk of contamination during the isolation process, which is important for maintaining the integrity of the isolated cells. Consumables are often designed to be compatible with a range of downstream applications, such as gene expression analysis and proteomics.

"The human cells segment is expected to hold a dominant share in 2023."

Based on the cell type, the market is segmented into human cells, and animal cells. The human cells segment is expected to hold a dominant share during the forecast period due to increasing investments for the research on human cells. Human cell lines, such as HeLa cells, have been used in research for decades and have become an important tool in many areas of medical research. The availability of established cell lines makes it easier for researchers to obtain and study human cells. The use of human cells in research can facilitate the translation of findings from the laboratory to the clinic, as human cells provide a more accurate representation of human physiology and disease. The use of human cells in research is generally more accepted by the public than the use of animal cells, as human cells are seen as more relevant and less controversial.

"The bone marrow cell isolation segment is likely to grow at highest CAGR during the forecast period of 2023-2028."

On the basis of cell source, the cell isolation market is segmented into adipose tissue, bone marrow, and cord blood/embryonic stem cells, and other cell sources. The bone marrow segment is projected to grow at the highest CAGR during the forecast period. The growth is attributed to commercialization of a number of bone marrow-derived stem cell-based products for various therapeutic applications.Bone marrow contains a diverse population of cells, including hematopoietic stem cells, mesenchymal stem cells, and immune cells. These cells can be isolated and used in a wide range of applications, including research, drug discovery, and cell-based therapies. The isolation of bone marrow cells has been well-established and standardized over the years, making it easier for researchers to obtain high-quality cells.

"The surface-marker based cell isolation segment is likely to grow at highest CAGR during the forecast period of 2023-2028."

On the basis of technique, the cell isolation market is segmented into centrifugation-based cell isolation, surface-marker based cell isolation, and filtration-based cell isolation. The surface-marker based isolation segment is projected to grow at the highest CAGR during the forecast period. The growth is attributed to increasing demand of this technique in the pharmaceutical industries. This is likely to propel segmental growth.

"In 2022, the biomolecule isolation segment held a dominant share."

Based on application, the cell isolation market is segmented into biomolecule isolation, stem cell research, cancer research, in vitro diagnostics, and tissue regeneration & regenerative medicine, and other applications. The biomolecule isolation segment held a dominant share of the cell isolation market. Technological advancements to project the market growth.

"The pharmaceutical & biotechnology companies segment is likely to grow at highest CAGR during the forecast period of 2023-2028."

Based on end user, the cell isolation market is segmented into pharmaceutical & biotechnology companies, academic and research institutes, hospitals and diagnostic laboratories, and other end users. The pharmaceutical & biotechnology companies segment to grow at the highest CAGR during the forecast period. Pharmaceutical and biotechnology companies' focus on R&D activities is one of the major factors anticipated to project market growth.

"Asia Pacific region is likely to grow at faster pace."

The cell isolation market is divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2022, North America accounted for the dominant share of cell isolation market. The dominance of the region is attributable to various factors such as the presence of dominant & key market players in the region, and technological advancements. Asia Pacific region is likely to grow at a faster pace owing to various factors such as the growing population, and government initiatives for infrastructural improvements of healthcare facilities are driving market growth in this region.

The primary interviews conducted for this report can be categorized as follows:

  • By Respondent: Supply Side- 80%, and Demand Side - 20%
  • By Designation (Supply Side): Managers - 35%, CXOs & Directors - 20%, Executives- 45%
  • By Region: North America -25%, Europe -30%, Asia-Pacific -30%, Latin America -10%, and Middle East and Africa -5%

Lists of Companies Profiled in the Report:

  • Danaher Corporation (US)
  • Merck KGaA (Germany)
  • Thermo Fisher Scientific, Inc. (US)
  • Becton, Dickinson and Company (US)
  • Terumo Corporation (Japan)
  • Agilent Technologies, Inc. (US)
  • Bio-Rad Laboratories, Inc. (US)
  • Corning Incorporated (US)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Miltenyi Biotec (Germany)
  • STEMCELL Technologies (Canada)
  • Alfa Laval (Sweden)
  • Sartorius AG (Germany)
  • Akadeum Life Sciences (US)
  • Bio-Techne (US)
  • PerkinElmer Inc. (US)
  • Invent Biotechnologies, Inc. (US)
  • Takara Bio, Inc. (Japan)
  • MiCareo Inc. (US)
  • Proteintech Group, Inc. (US)
  • QIAGEN (Germany)
  • Lonza (Switzerland)
  • Promega Corporation (US)
  • PluriSelect Life Science UG (Haftungsbeschrankt) & Co. KG (Germany)
  • MagBio Genomics (US)

Research Coverage:

This report provides a detailed picture of the cell isolation market. It aims at estimating the size and future growth potential of the market across different segments, such as product, cell type, cell source, technique, application, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall single-use bioreactors market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, challenges, trends, and opportunities.

The report provides insights on the following pointers:

  • Analysis of key drivers (Increasing government funding for cell-based research, increasing number of patients suffering from cancer and infectious diseases, technological advancements), restraints (Ethical & safety issues related to embryonic stem cell isolation, high cost of cell-based research), opportunities (Growth opportunities in emerging markets) and challenges (Obstacles to develop cell therapies) influencing the growth of cell isolation market.
  • Product Development/Innovation: Detailed insights on newly launched products, and technological assessment of the cell isolation market.
  • Market Development: Comprehensive information about lucrative markets - the report analyses the cell isolation market across varied regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the cell isolation market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies and product offerings of leading players in the cell isolation market. The report also helps stakeholders understand the pulse of single-use bioreactors market and provides them information on key market drivers, restraints, challenges, and opportunities along with market trends.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS
  • 1.3 MARKET SCOPE
    • FIGURE 1 CELL ISOLATION MARKET SEGMENTATION
    • 1.3.1 YEARS CONSIDERED
  • 1.4 CURRENCY
  • 1.5 LIMITATIONS
  • 1.6 STAKEHOLDERS
  • 1.7 SUMMARY OF CHANGES
    • 1.7.1 RECESSION IMPACT

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH APPROACH
    • FIGURE 2 RESEARCH DESIGN
    • 2.1.1 SECONDARY RESEARCH
    • 2.1.2 PRIMARY RESEARCH
    • FIGURE 3 CELL ISOLATION MARKET: PRIMARY RESPONDENTS
  • 2.2 MARKET ESTIMATION METHODOLOGY
    • FIGURE 4 MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS, 2022
    • FIGURE 5 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2022
    • FIGURE 6 MARKET SIZE ESTIMATION: APPROACH 2 (TOP-DOWN-BASED ESTIMATION), 2022
    • 2.2.1 INSIGHTS FROM PRIMARY EXPERTS
    • FIGURE 7 INSIGHTS ON CELL ISOLATION MARKET FROM PRIMARY EXPERTS
  • 2.3 MARKET GROWTH RATE PROJECTIONS
    • FIGURE 8 CELL ISOLATION MARKET: CAGR PROJECTIONS, 2023-2028
    • FIGURE 9 CELL ISOLATION MARKET (DEMAND SIDE): GROWTH ANALYSIS OF DEMAND-SIDE FACTORS
  • 2.4 DATA TRIANGULATION
    • FIGURE 10 DATA TRIANGULATION METHODOLOGY
  • 2.5 RESEARCH ASSUMPTIONS
  • 2.6 RISK ANALYSIS
  • 2.7 RECESSION IMPACT
    • TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021-2027 (% GROWTH)

3 EXECUTIVE SUMMARY

    • FIGURE 11 CELL ISOLATION MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
    • FIGURE 12 CELL ISOLATION MARKET, BY CELL TYPE, 2023 VS. 2028 (USD MILLION)
    • FIGURE 13 CELL ISOLATION MARKET, BY CELL SOURCE, 2023 VS. 2028 (USD MILLION)
    • FIGURE 14 CELL ISOLATION MARKET, BY TECHNIQUE, 2023 VS. 2028 (USD MILLION)
    • FIGURE 15 CELL ISOLATION MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
    • FIGURE 16 CELL ISOLATION MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
    • FIGURE 17 GEOGRAPHICAL SNAPSHOT OF CELL ISOLATION MARKET

4 PREMIUM INSIGHTS

  • 4.1 CELL ISOLATION MARKET OVERVIEW
    • FIGURE 18 INCREASING FUNDING FOR CELL-BASED RESEARCH TO DRIVE GROWTH
  • 4.2 NORTH AMERICA: CELL ISOLATION MARKET, BY PRODUCT AND COUNTRY (2022)
    • FIGURE 19 CONSUMABLES ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
  • 4.3 CELL ISOLATION MARKET SHARE, BY APPLICATION, 2023 VS. 2028
    • FIGURE 20 BIOMOLECULE ISOLATION SEGMENT TO CONTINUE TO DOMINATE MARKET IN 2028
  • 4.4 CELL ISOLATION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 21 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 22 CELL ISOLATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • TABLE 2 CELL ISOLATION MARKET: IMPACT ANALYSIS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing government funding for cell-based research
    • TABLE 3 NIH FUNDING FOR CELL-BASED RESEARCH, 2019-2022 (USD MILLION)
      • 5.2.1.2 Increasing number of patients suffering from cancer and infectious diseases
    • TABLE 4 INCIDENCE OF CANCER, BY REGION, 2020
    • TABLE 5 IMPORTANT STATISTICS ON INFECTIOUS DISEASES
      • 5.2.1.3 Technological advancements
      • 5.2.1.4 Growing focus on personalized medicine
    • TABLE 6 FDA APPROVAL RATE FOR PERSONALIZED MEDICINES, 2015-2021
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Ethical & safety issues related to embryonic stem cell isolation
      • 5.2.2.2 High cost of cell-based research
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Growth opportunities in emerging markets
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Obstacles to developing cell therapies
  • 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
    • FIGURE 23 REVENUE SHIFT AND NEW REVENUE POCKETS
  • 5.4 PRICING ANALYSIS
    • TABLE 7 PRICE OF KEY CELL ISOLATION PRODUCTS OF KEY COMPANIES (2022)
  • 5.5 VALUE CHAIN ANALYSIS
    • FIGURE 24 CELL ISOLATION MARKET: VALUE CHAIN ANALYSIS
  • 5.6 ECOSYSTEM ANALYSIS
    • TABLE 8 CELL ISOLATION MARKET ECOSYSTEM
  • 5.7 REGULATORY ANALYSIS
  • 5.8 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 9 CELL ISOLATION/ CELL SEPARATION MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.8.1 THREAT FROM NEW ENTRANTS
    • 5.8.2 THREAT FROM SUBSTITUTES
    • 5.8.3 BARGAINING POWER OF SUPPLIERS
    • 5.8.4 BARGAINING POWER OF BUYERS
    • 5.8.5 DEGREE OF COMPETITION
  • 5.9 KEY CONFERENCES & EVENTS IN 2023-2024
    • TABLE 10 CELL ISOLATION MARKET: DETAILED LIST OF CONFERENCES & EVENTS
  • 5.10 TECHNOLOGY ANALYSIS
    • 5.10.1 MICROFLUIDICS
    • 5.10.2 MAGNETIC CELL ISOLATION
    • 5.10.3 FLUORESCENCE-ACTIVATED CELL SORTING (FACS)
    • 5.10.4 ACOUSTIC CELL ISOLATION
    • 5.10.5 ACOUSTO-FLUIDIC CELL ISOLATION
  • 5.11 KEY STAKEHOLDERS & BUYING CRITERIA
    • FIGURE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF CELL ISOLATION PRODUCTS
    • FIGURE 26 KEY BUYING CRITERIA FOR CELL ISOLATION PRODUCTS
  • 5.12 TRADE ANALYSIS
    • TABLE 11 EXPORT DATA (TOP 10 COUNTRIES)
    • TABLE 12 IMPORT DATA (TOP 10 COUNTRIES)
  • 5.13 PATENT ANALYSIS
    • FIGURE 27 PATENT APPLICATIONS RELATED TO CELL ISOLATION, JANUARY 2012-MARCH 2023
    • TABLE 13 LIST OF PATENTS IN CELL ISOLATION MARKET

6 CELL ISOLATION MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
    • TABLE 14 CELL ISOLATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • 6.2 CONSUMABLES
    • TABLE 15 CELL ISOLATION CONSUMABLES MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 16 NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 17 EUROPE: CELL ISOLATION CONSUMABLES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 18 ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 19 LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 20 CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 6.2.1 REAGENTS, KITS, MEDIA, AND SERA
      • 6.2.1.1 Disposable nature of reagents and assay kits to drive consistent usage and frequent purchases
    • TABLE 21 CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS, KITS, MEDIA, AND SERA, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 22 NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS, KITS, MEDIA, AND SERA, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 23 EUROPE: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS, KITS, MEDIA, AND SERA, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 24 ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS, KITS, MEDIA, AND SERA, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 25 LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS, KITS, MEDIA, AND SERA, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.2.2 BEADS
    • TABLE 26 CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 27 NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 28 EUROPE: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 29 ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 30 LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 31 CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021-2028 (USD MILLION)
      • 6.2.2.1 Magnetic beads
        • 6.2.2.1.1 Growing demand for magnetic beads in T-cell and stem cell isolation to drive growth
    • TABLE 32 CELL ISOLATION CONSUMABLES MARKET FOR MAGNETIC BEADS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 33 NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR MAGNETIC BEADS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 34 EUROPE: CELL ISOLATION CONSUMABLES MARKET FOR MAGNETIC BEADS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 35 ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET FOR MAGNETIC BEADS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 36 LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR MAGNETIC BEADS, BY COUNTRY, 2021-2028 (USD MILLION)
      • 6.2.2.2 Fluorescent beads
        • 6.2.2.2.1 Advantages of fluorescent beads to boost adoption
    • TABLE 37 CELL ISOLATION CONSUMABLES MARKET FOR FLUORESCENT BEADS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 38 NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR FLUORESCENT BEADS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 39 EUROPE: CELL ISOLATION CONSUMABLES MARKET FOR FLUORESCENT BEADS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 40 ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET FOR FLUORESCENT BEADS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 41 LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR FLUORESCENT BEADS, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.2.3 DISPOSABLES
      • 6.2.3.1 Growing government investments in research to boost growth
    • TABLE 42 CELL ISOLATION CONSUMABLES MARKET FOR DISPOSABLES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 43 NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR DISPOSABLES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 44 EUROPE: CELL ISOLATION CONSUMABLES MARKET FOR DISPOSABLES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 45 ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET FOR DISPOSABLES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 46 LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR DISPOSABLES, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.3 INSTRUMENTS
    • TABLE 47 CELL ISOLATION INSTRUMENTS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 48 NORTH AMERICA: CELL ISOLATION INSTRUMENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 49 EUROPE: CELL ISOLATION INSTRUMENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 50 ASIA PACIFIC: CELL ISOLATION INSTRUMENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 51 LATIN AMERICA: CELL ISOLATION INSTRUMENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 52 CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 6.3.1 CENTRIFUGES
      • 6.3.1.1 Growing use of centrifuges in pharma-biotech industry to boost market
    • TABLE 53 CELL ISOLATION INSTRUMENTS MARKET FOR CENTRIFUGES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 54 NORTH AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR CENTRIFUGES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 55 EUROPE: CELL ISOLATION INSTRUMENTS MARKET FOR CENTRIFUGES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 56 ASIA PACIFIC: CELL ISOLATION INSTRUMENTS MARKET FOR CENTRIFUGES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 57 LATIN AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR CENTRIFUGES, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.3.2 CELL SORTERS
      • 6.3.2.1 Launch of innovative and cost-effective cell sorters to support market
    • TABLE 58 CELL ISOLATION INSTRUMENTS MARKET FOR CELL SORTERS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 59 NORTH AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR CELL SORTERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 60 EUROPE: CELL ISOLATION INSTRUMENTS MARKET FOR CELL SORTERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 61 ASIA PACIFIC: CELL ISOLATION INSTRUMENTS MARKET FOR CELL SORTERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 62 LATIN AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR CELL SORTERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.3.3 MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS
      • 6.3.3.1 Growing focus on personalized medicine to drive segmental growth
    • TABLE 63 CELL ISOLATION INSTRUMENTS MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 64 NORTH AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 65 EUROPE: CELL ISOLATION INSTRUMENTS MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 66 ASIA PACIFIC: CELL ISOLATION INSTRUMENTS MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 67 LATIN AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.3.4 FILTRATION SYSTEMS
      • 6.3.4.1 Increasing research activities in cell biology to boost market
    • TABLE 68 CELL ISOLATION INSTRUMENTS MARKET FOR FILTRATION SYSTEMS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 69 NORTH AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 70 EUROPE: CELL ISOLATION INSTRUMENTS MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 71 ASIA PACIFIC: CELL ISOLATION INSTRUMENTS MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 72 LATIN AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2021-2028 (USD MILLION)

7 CELL ISOLATION MARKET, BY CELL TYPE

  • 7.1 INTRODUCTION
    • TABLE 73 CELL ISOLATION MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
  • 7.2 HUMAN CELLS
    • TABLE 74 CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 75 CELL ISOLATION MARKET FOR HUMAN CELLS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 76 NORTH AMERICA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 77 EUROPE: CELL ISOLATION MARKET FOR HUMAN CELLS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 78 ASIA PACIFIC: CELL ISOLATION MARKET FOR HUMAN CELLS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 79 LATIN AMERICA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY COUNTRY, 2021-2028 (USD MILLION)
    • 7.2.1 DIFFERENTIATED CELLS
      • 7.2.1.1 Growing investments by market players to develop new and innovative products to support growth
    • TABLE 80 CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 81 NORTH AMERICA: CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 82 EUROPE: CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 83 ASIA PACIFIC: CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 84 LATIN AMERICA: CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY, 2021-2028 (USD MILLION)
    • 7.2.2 STEM CELLS
      • 7.2.2.1 Rising government initiatives focused on supporting stem cell research to drive market
    • TABLE 85 CELL ISOLATION MARKET FOR STEM CELLS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 86 NORTH AMERICA: CELL ISOLATION MARKET FOR STEM CELLS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 87 EUROPE: CELL ISOLATION MARKET FOR STEM CELLS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 88 ASIA PACIFIC: CELL ISOLATION MARKET FOR STEM CELLS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 89 LATIN AMERICA: CELL ISOLATION MARKET FOR STEM CELLS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.3 ANIMAL CELLS
    • 7.3.1 INCREASING INVESTMENTS IN BIOPHARMACEUTICAL R&D FOR VACCINE AND DRUG DEVELOPMENT TO BOOST MARKET
    • TABLE 90 CELL ISOLATION MARKET FOR ANIMAL CELLS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 91 NORTH AMERICA: CELL ISOLATION MARKET FOR ANIMAL CELLS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 92 EUROPE: CELL ISOLATION MARKET FOR ANIMAL CELLS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 93 ASIA PACIFIC: CELL ISOLATION MARKET FOR ANIMAL CELLS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 94 LATIN AMERICA: CELL ISOLATION MARKET FOR ANIMAL CELLS, BY COUNTRY, 2021-2028 (USD MILLION)

8 CELL ISOLATION MARKET, BY CELL SOURCE

  • 8.1 INTRODUCTION
    • TABLE 95 CELL ISOLATION MARKET, BY CELL SOURCE, 2021-2028 (USD MILLION)
  • 8.2 BONE MARROW
    • 8.2.1 GROWING NUMBER OF COMMERCIALIZED BONE MARROW-DERIVED STEM CELLS TO DRIVE MARKET
    • TABLE 96 CELL ISOLATION MARKET FOR BONE MARROW-DERIVED CELLS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 97 NORTH AMERICA: CELL ISOLATION MARKET FOR BONE MARROW-DERIVED CELLS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 98 EUROPE: CELL ISOLATION MARKET FOR BONE MARROW-DERIVED CELLS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 99 ASIA PACIFIC: CELL ISOLATION MARKET FOR BONE MARROW-DERIVED CELLS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 100 LATIN AMERICA: CELL ISOLATION MARKET FOR BONE MARROW-DERIVED CELLS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.3 ADIPOSE TISSUE
    • 8.3.1 ABILITY OF ADIPOSE STEM/STROMAL CELLS TO GENERATE VARIETY OF OTHER CELL TYPES TO DRIVE DEMAND
    • TABLE 101 CELL ISOLATION MARKET FOR ADIPOSE TISSUE-DERIVED CELLS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 102 NORTH AMERICA: CELL ISOLATION MARKET FOR ADIPOSE TISSUE-DERIVED CELLS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 103 EUROPE: CELL ISOLATION MARKET FOR ADIPOSE TISSUE-DERIVED CELLS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 104 ASIA PACIFIC: CELL ISOLATION MARKET FOR ADIPOSE TISSUE-DERIVED CELLS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 105 LATIN AMERICA: CELL ISOLATION MARKET FOR ADIPOSE TISSUE-DERIVED CELLS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.4 CORD BLOOD/EMBRYONIC STEM CELLS
    • 8.4.1 HIGH THERAPEUTIC POTENCY OF CORD BLOOD/EMBRYONIC STEM CELLS TO SUPPORT MARKET
    • TABLE 106 CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 107 NORTH AMERICA: CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 108 EUROPE: CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 109 ASIA PACIFIC: CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 110 LATIN AMERICA: CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.5 OTHER CELL SOURCES
    • TABLE 111 CELL ISOLATION MARKET FOR OTHER CELL SOURCES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 112 NORTH AMERICA: CELL ISOLATION MARKET FOR OTHER CELL SOURCES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 113 EUROPE: CELL ISOLATION MARKET FOR OTHER CELL SOURCES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 114 ASIA PACIFIC: CELL ISOLATION MARKET FOR OTHER CELL SOURCES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 115 LATIN AMERICA: CELL ISOLATION MARKET FOR OTHER CELL SOURCES, BY COUNTRY, 2021-2028 (USD MILLION)

9 CELL ISOLATION MARKET, BY TECHNIQUE

  • 9.1 INTRODUCTION
    • TABLE 116 CELL ISOLATION MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
  • 9.2 CENTRIFUGATION-BASED CELL ISOLATION
    • 9.2.1 COST-EFFECTIVENESS OF TECHNIQUE IN BOTH SMALL-SCALE AND LARGE-SCALE OPERATIONS TO DRIVE MARKET
    • TABLE 117 CENTRIFUGATION-BASED CELL ISOLATION MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 118 NORTH AMERICA: CENTRIFUGATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 119 EUROPE: CENTRIFUGATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 120 ASIA PACIFIC: CENTRIFUGATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 121 LATIN AMERICA: CENTRIFUGATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 9.3 SURFACE MARKER-BASED CELL ISOLATION
    • 9.3.1 WIDE USAGE IN BIOPHARMACEUTICAL AND BIOTECH INDUSTRIES TO SUPPORT GROWTH
    • TABLE 122 SURFACE MARKER-BASED CELL ISOLATION MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 123 NORTH AMERICA: SURFACE MARKER-BASED CELL ISOLATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 124 EUROPE: SURFACE MARKER-BASED CELL ISOLATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 125 ASIA PACIFIC: SURFACE MARKER-BASED CELL ISOLATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 126 LATIN AMERICA: SURFACE MARKER-BASED CELL ISOLATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 9.4 FILTRATION-BASED CELL ISOLATION
    • 9.4.1 LOW COST OF FILTRATION TECHNIQUE TO BOOST ADOPTION
    • TABLE 127 FILTRATION-BASED CELL ISOLATION MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 128 NORTH AMERICA: FILTRATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 129 EUROPE: FILTRATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 130 ASIA PACIFIC: FILTRATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 131 LATIN AMERICA: FILTRATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)

10 CELL ISOLATION MARKET, BY APPLICATION

  • 10.1 INTRODUCTION
    • TABLE 132 CELL ISOLATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • 10.2 BIOMOLECULE ISOLATION
    • 10.2.1 BIOMOLECULE ISOLATION SEGMENT TO DOMINATE CELL ISOLATION MARKET DURING FORECAST PERIOD
    • TABLE 133 CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 134 NORTH AMERICA: CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 135 EUROPE: CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 136 ASIA PACIFIC: CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 137 LATIN AMERICA: CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 10.3 CANCER RESEARCH
    • 10.3.1 HIGH DISEASE INCIDENCE TO FUEL DEMAND FOR ADVANCED TREATMENTS
    • TABLE 138 CELL ISOLATION MARKET FOR CANCER RESEARCH APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 139 NORTH AMERICA: CELL ISOLATION MARKET FOR CANCER RESEARCH APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 140 EUROPE: CELL ISOLATION MARKET FOR CANCER RESEARCH APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 141 ASIA PACIFIC: CELL ISOLATION MARKET FOR CANCER RESEARCH APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 142 LATIN AMERICA: CELL ISOLATION MARKET FOR CANCER RESEARCH APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 10.4 STEM CELL RESEARCH
    • 10.4.1 INCREASING FUNDING IN STEM CELL RESEARCH TO SUPPORT MARKET GROWTH
    • TABLE 143 CELL ISOLATION MARKET FOR STEM CELL RESEARCH APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 144 NORTH AMERICA: CELL ISOLATION MARKET FOR STEM CELL RESEARCH APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 145 EUROPE: CELL ISOLATION MARKET FOR STEM CELL RESEARCH APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 146 ASIA PACIFIC: CELL ISOLATION MARKET FOR STEM CELL RESEARCH APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 147 LATIN AMERICA: CELL ISOLATION MARKET FOR STEM CELL RESEARCH APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 10.5 TISSUE REGENERATION & REGENERATIVE MEDICINE
    • 10.5.1 GROWING REGENERATIVE MEDICINE INITIATIVES TO SUPPORT MARKET
    • TABLE 148 CELL ISOLATION MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 149 NORTH AMERICA: CELL ISOLATION MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 150 EUROPE: CELL ISOLATION MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 151 ASIA PACIFIC: CELL ISOLATION MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 152 LATIN AMERICA: CELL ISOLATION MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 10.6 IN VITRO DIAGNOSTICS
    • 10.6.1 RISING DISEASE INCIDENCE TO DRIVE DEMAND FOR INNOVATIVE THERAPIES AND DIAGNOSTICS
    • TABLE 153 CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTIC APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 154 NORTH AMERICA: CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 155 EUROPE: CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 156 ASIA PACIFIC: CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 157 LATIN AMERICA: CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 10.7 OTHER APPLICATIONS
    • TABLE 158 CELL ISOLATION MARKET FOR OTHER APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 159 NORTH AMERICA: CELL ISOLATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 160 EUROPE: CELL ISOLATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 161 ASIA PACIFIC: CELL ISOLATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 162 LATIN AMERICA: CELL ISOLATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)

11 CELL ISOLATION MARKET, BY END USER

  • 11.1 INTRODUCTION
    • TABLE 163 CELL ISOLATION MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 11.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    • 11.2.1 FAVORABLE R&D INVESTMENTS TO BOOST MARKET GROWTH
    • TABLE 164 CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 165 NORTH AMERICA: CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 166 EUROPE: CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 167 ASIA PACIFIC: CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 168 LATIN AMERICA: CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
  • 11.3 ACADEMIC & RESEARCH INSTITUTES
    • 11.3.1 RISING FUNDING FOR CELL-BASED RESEARCH TO DRIVE MARKET GROWTH
    • TABLE 169 CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 170 NORTH AMERICA: CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 171 EUROPE: CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 172 ASIA PACIFIC: CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 173 LATIN AMERICA: CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
  • 11.4 HOSPITALS & DIAGNOSTIC LABORATORIES
    • 11.4.1 INCREASING NUMBER OF HOSPITALS IN EMERGING COUNTRIES TO CONTRIBUTE TO MARKET GROWTH
    • TABLE 174 CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 175 NORTH AMERICA: CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 176 EUROPE: CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 177 ASIA PACIFIC: CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 178 LATIN AMERICA: CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2021-2028 (USD MILLION)
  • 11.5 OTHER END USERS
    • TABLE 179 CELL ISOLATION MARKET FOR OTHER END USERS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 180 NORTH AMERICA: CELL ISOLATION MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 181 EUROPE: CELL ISOLATION MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 182 ASIA PACIFIC: CELL ISOLATION MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 183 LATIN AMERICA: CELL ISOLATION MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)

12 CELL ISOLATION MARKET, BY REGION

  • 12.1 INTRODUCTION
    • TABLE 184 CELL ISOLATION MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 12.2 NORTH AMERICA
    • FIGURE 28 NORTH AMERICA: CELL ISOLATION MARKET SNAPSHOT
    • TABLE 185 NORTH AMERICA: CELL ISOLATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 186 NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 187 NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 188 NORTH AMERICA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 189 NORTH AMERICA: CELL ISOLATION MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
    • TABLE 190 NORTH AMERICA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 191 NORTH AMERICA: CELL ISOLATION MARKET, BY CELL SOURCE, 2021-2028 (USD MILLION)
    • TABLE 192 NORTH AMERICA: CELL ISOLATION MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 193 NORTH AMERICA: CELL ISOLATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 194 NORTH AMERICA: CELL ISOLATION MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 12.2.1 US
      • 12.2.1.1 US to dominate North American cell isolation market during forecast period
    • TABLE 195 US: CELL ISOLATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 196 US: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 197 US: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 198 US: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 199 US: CELL ISOLATION MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
    • TABLE 200 US: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 201 US: CELL ISOLATION MARKET, BY CELL SOURCE, 2021-2028 (USD MILLION)
    • TABLE 202 US: CELL ISOLATION MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 203 US: CELL ISOLATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 204 US: CELL ISOLATION MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 12.2.2 CANADA
      • 12.2.2.1 Increasing funding for research in regenerative medicine to support market growth in Canada
    • TABLE 205 CANADA: CELL ISOLATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 206 CANADA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 207 CANADA: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 208 CANADA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 209 CANADA: CELL ISOLATION MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
    • TABLE 210 CANADA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 211 CANADA: CELL ISOLATION MARKET, BY CELL SOURCE, 2021-2028 (USD MILLION)
    • TABLE 212 CANADA: CELL ISOLATION MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 213 CANADA: CELL ISOLATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 214 CANADA: CELL ISOLATION MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 12.2.3 NORTH AMERICA: RECESSION IMPACT
  • 12.3 EUROPE
    • TABLE 215 EUROPE: CELL ISOLATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 216 EUROPE: CELL ISOLATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 217 EUROPE: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 218 EUROPE: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 219 EUROPE: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 220 EUROPE: CELL ISOLATION MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
    • TABLE 221 EUROPE: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 222 EUROPE: CELL ISOLATION MARKET, BY CELL SOURCE, 2021-2028 (USD MILLION)
    • TABLE 223 EUROPE: CELL ISOLATION MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 224 EUROPE: CELL ISOLATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 225 EUROPE: CELL ISOLATION MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 12.3.1 GERMANY
      • 12.3.1.1 Germany to be fastest-growing market for cell isolation in Europe
    • TABLE 226 GERMANY: CELL ISOLATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 227 GERMANY: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 228 GERMANY: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 229 GERMANY: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 230 GERMANY: CELL ISOLATION MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
    • TABLE 231 GERMANY: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 232 GERMANY: CELL ISOLATION MARKET, BY CELL SOURCE, 2021-2028 (USD MILLION)
    • TABLE 233 GERMANY: CELL ISOLATION MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 234 GERMANY: CELL ISOLATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 235 GERMANY: CELL ISOLATION MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 12.3.2 UK
      • 12.3.2.1 Government investments in stem cell research to drive market for cell isolation in UK
    • TABLE 236 UK: CELL ISOLATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 237 UK: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 238 UK: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 239 UK: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 240 UK: CELL ISOLATION MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
    • TABLE 241 UK: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 242 UK: CELL ISOLATION MARKET, BY CELL SOURCE, 2021-2028 (USD MILLION)
    • TABLE 243 UK: CELL ISOLATION MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 244 UK: CELL ISOLATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 245 UK: CELL ISOLATION MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 12.3.3 FRANCE
      • 12.3.3.1 Increasing prevalence of various chronic and infectious diseases to drive market growth
    • TABLE 246 FRANCE: CELL ISOLATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 247 FRANCE: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 248 FRANCE: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 249 FRANCE: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 250 FRANCE: CELL ISOLATION MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
    • TABLE 251 FRANCE: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 252 FRANCE: CELL ISOLATION MARKET, BY CELL SOURCE, 2021-2028 (USD MILLION)
    • TABLE 253 FRANCE: CELL ISOLATION MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 254 FRANCE: CELL ISOLATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 255 FRANCE: CELL ISOLATION MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 12.3.4 ITALY
      • 12.3.4.1 Increasing number of cell biology seminars and conferences to fuel adoption of cell isolation products
    • TABLE 256 ITALY: CELL ISOLATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 257 ITALY: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 258 ITALY: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 259 ITALY: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 260 ITALY: CELL ISOLATION MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
    • TABLE 261 ITALY: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 262 ITALY: CELL ISOLATION MARKET, BY CELL SOURCE, 2021-2028 (USD MILLION)
    • TABLE 263 ITALY: CELL ISOLATION MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 264 ITALY: CELL ISOLATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 265 ITALY: CELL ISOLATION MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 12.3.5 SPAIN
      • 12.3.5.1 Increasing funding from private and public organizations to aid growth
    • TABLE 266 SPAIN: CELL ISOLATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 267 SPAIN: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 268 SPAIN: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 269 SPAIN: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 270 SPAIN: CELL ISOLATION MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
    • TABLE 271 SPAIN: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 272 SPAIN: CELL ISOLATION MARKET, BY CELL SOURCE, 2021-2028 (USD MILLION)
    • TABLE 273 SPAIN: CELL ISOLATION MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 274 SPAIN: CELL ISOLATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 275 SPAIN: CELL ISOLATION MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 12.3.6 REST OF EUROPE
    • TABLE 276 REST OF EUROPE: CELL ISOLATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 277 REST OF EUROPE: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 278 REST OF EUROPE: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 279 REST OF EUROPE: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 280 REST OF EUROPE: CELL ISOLATION MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
    • TABLE 281 REST OF EUROPE: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 282 REST OF EUROPE: CELL ISOLATION MARKET, BY CELL SOURCE, 2021-2028 (USD MILLION)
    • TABLE 283 REST OF EUROPE: CELL ISOLATION MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 284 REST OF EUROPE: CELL ISOLATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 285 REST OF EUROPE: CELL ISOLATION MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 12.3.7 EUROPE: RECESSION IMPACT
  • 12.4 ASIA PACIFIC
    • FIGURE 29 ASIA PACIFIC: CELL ISOLATION MARKET SNAPSHOT
    • TABLE 286 ASIA PACIFIC: CELL ISOLATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 287 ASIA PACIFIC: CELL ISOLATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 288 ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 289 ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 290 ASIA PACIFIC: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 291 ASIA PACIFIC: CELL ISOLATION MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
    • TABLE 292 ASIA PACIFIC: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 293 ASIA PACIFIC: CELL ISOLATION MARKET, BY CELL SOURCE, 2021-2028 (USD MILLION)
    • TABLE 294 ASIA PACIFIC: CELL ISOLATION MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 295 ASIA PACIFIC: CELL ISOLATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 296 ASIA PACIFIC: CELL ISOLATION MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 12.4.1 CHINA
      • 12.4.1.1 Growing cell therapy-based research in China to boost market
    • TABLE 297 CHINA: CELL ISOLATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 298 CHINA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 299 CHINA: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 300 CHINA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 301 CHINA: CELL ISOLATION MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
    • TABLE 302 CHINA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 303 CHINA: CELL ISOLATION MARKET, BY CELL SOURCE, 2021-2028 (USD MILLION)
    • TABLE 304 CHINA: CELL ISOLATION MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 305 CHINA: CELL ISOLATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 306 CHINA: CELL ISOLATION MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 12.4.2 JAPAN
      • 12.4.2.1 Increasing geriatric population and subsequent rise in prevalence of chronic diseases to drive market
    • TABLE 307 JAPAN: CELL ISOLATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 308 JAPAN: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 309 JAPAN: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 310 JAPAN: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 311 JAPAN: CELL ISOLATION MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
    • TABLE 312 JAPAN: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 313 JAPAN: CELL ISOLATION MARKET, BY CELL SOURCE, 2021-2028 (USD MILLION)
    • TABLE 314 JAPAN: CELL ISOLATION MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 315 JAPAN: CELL ISOLATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 316 JAPAN: CELL ISOLATION MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 12.4.3 INDIA
      • 12.4.3.1 Rising incidence of chronic and infectious diseases to drive demand for cell isolation products
    • TABLE 317 INDIA: CELL ISOLATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 318 INDIA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 319 INDIA: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 320 INDIA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 321 INDIA: CELL ISOLATION MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
    • TABLE 322 INDIA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 323 INDIA: CELL ISOLATION MARKET, BY CELL SOURCE, 2021-2028 (USD MILLION)
    • TABLE 324 INDIA: CELL ISOLATION MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 325 INDIA: CELL ISOLATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 326 INDIA: CELL ISOLATION MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 12.4.4 AUSTRALIA
      • 12.4.4.1 Rising stem cell research to drive demand for cell isolation products
    • TABLE 327 AUSTRALIA: CELL ISOLATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 328 AUSTRALIA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 329 AUSTRALIA: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 330 AUSTRALIA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 331 AUSTRALIA: CELL ISOLATION MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
    • TABLE 332 AUSTRALIA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 333 AUSTRALIA: CELL ISOLATION MARKET, BY CELL SOURCE, 2021-2028 (USD MILLION)
    • TABLE 334 AUSTRALIA: CELL ISOLATION MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 335 AUSTRALIA: CELL ISOLATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 336 AUSTRALIA: CELL ISOLATION MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 12.4.5 REST OF ASIA PACIFIC
    • TABLE 337 REST OF ASIA PACIFIC: CELL ISOLATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 338 REST OF ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 339 REST OF ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 340 REST OF ASIA PACIFIC: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 341 REST OF ASIA PACIFIC: CELL ISOLATION MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
    • TABLE 342 REST OF ASIA PACIFIC: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 343 REST OF ASIA PACIFIC: CELL ISOLATION MARKET, BY CELL SOURCE, 2021-2028 (USD MILLION)
    • TABLE 344 REST OF ASIA PACIFIC: CELL ISOLATION MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 345 REST OF ASIA PACIFIC: CELL ISOLATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 346 REST OF ASIA PACIFIC: CELL ISOLATION MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 12.4.6 ASIA PACIFIC: RECESSION IMPACT
  • 12.5 LATIN AMERICA
    • TABLE 347 LATIN AMERICA: CELL ISOLATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 348 LATIN AMERICA: CELL ISOLATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 349 LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 350 LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 351 LATIN AMERICA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 352 LATIN AMERICA: CELL ISOLATION MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
    • TABLE 353 LATIN AMERICA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 354 LATIN AMERICA: CELL ISOLATION MARKET, BY CELL SOURCE, 2021-2028 (USD MILLION)
    • TABLE 355 LATIN AMERICA: CELL ISOLATION MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 356 LATIN AMERICA: CELL ISOLATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 357 LATIN AMERICA: CELL ISOLATION MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 12.5.1 BRAZIL
      • 12.5.1.1 Expansion of leading market players in country to drive market growth
    • TABLE 358 BRAZIL: CELL ISOLATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 359 BRAZIL: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 360 BRAZIL: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 361 BRAZIL: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 362 BRAZIL: CELL ISOLATION MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
    • TABLE 363 BRAZIL: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 364 BRAZIL CELL ISOLATION MARKET, BY CELL SOURCE, 2021-2028 (USD MILLION)
    • TABLE 365 BRAZIL: CELL ISOLATION MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 366 BRAZIL: CELL ISOLATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 367 BRAZIL: CELL ISOLATION MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 12.5.2 REST OF LATIN AMERICA
    • TABLE 368 REST OF LATIN AMERICA: CELL ISOLATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 369 REST OF LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 370 REST OF LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 371 REST OF LATIN AMERICA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 372 REST OF LATIN AMERICA: CELL ISOLATION MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
    • TABLE 373 REST OF LATIN AMERICA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 374 REST OF LATIN AMERICA: CELL ISOLATION MARKET, BY CELL SOURCE, 2021-2028 (USD MILLION)
    • TABLE 375 REST OF LATIN AMERICA: CELL ISOLATION MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 376 REST OF LATIN AMERICA: CELL ISOLATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 377 REST OF LATIN AMERICA: CELL ISOLATION MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 12.5.3 LATIN AMERICA: RECESSION IMPACT
  • 12.6 MIDDLE EAST & AFRICA
    • 12.6.1 GROWING PHARMACEUTICAL INDUSTRY IN MEA TO DRIVE MARKET GROWTH
    • TABLE 378 MIDDLE EAST & AFRICA: CELL ISOLATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 379 MIDDLE EAST & AFRICA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 380 MIDDLE EAST & AFRICA: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 381 MIDDLE EAST & AFRICA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 382 MIDDLE EAST & AFRICA: CELL ISOLATION MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
    • TABLE 383 MIDDLE EAST & AFRICA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 384 MIDDLE EAST & AFRICA: CELL ISOLATION MARKET, BY CELL SOURCE, 2021-2028 (USD MILLION)
    • TABLE 385 MIDDLE EAST & AFRICA: CELL ISOLATION MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 386 MIDDLE EAST & AFRICA: CELL ISOLATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 387 MIDDLE EAST & AFRICA: CELL ISOLATION MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 12.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT

13 COMPETITIVE LANDSCAPE

  • 13.1 INTRODUCTION
  • 13.2 STRATEGIES ADOPTED BY KEY PLAYERS
    • FIGURE 30 CELL ISOLATION MARKET: STRATEGIES ADOPTED
  • 13.3 MARKET SHARE ANALYSIS
    • FIGURE 31 CELL ISOLATION MARKET: MARKET SHARE ANALYSIS, BY KEY PLAYER (2022)
    • TABLE 388 CELL ISOLATION MARKET: DEGREE OF COMPETITION
  • 13.4 REVENUE ANALYSIS
    • FIGURE 32 CELL ISOLATION MARKET: REVENUE ANALYSIS, BY KEY PLAYER (2020-2022)
  • 13.5 COMPANY EVALUATION MATRIX
    • FIGURE 33 CELL ISOLATION MARKET: COMPANY EVALUATION MATRIX, 2022
    • 13.5.1 STARS
    • 13.5.2 EMERGING LEADERS
    • 13.5.3 PERVASIVE PLAYERS
    • 13.5.4 PARTICIPANTS
  • 13.6 COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS
    • 13.6.1 OVERALL COMPANY FOOTPRINT (25 COMPANIES)
    • TABLE 389 END-USER, PRODUCT, AND REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS
    • 13.6.2 END-USER FOOTPRINT OF COMPANIES (25 COMPANIES)
    • TABLE 390 END-USER FOOTPRINT ANALYSIS OF KEY PLAYERS
    • 13.6.3 REGIONAL FOOTPRINT OF COMPANIES (25 COMPANIES)
    • TABLE 391 REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS
    • 13.6.4 PRODUCT FOOTPRINT OF COMPANIES (25 COMPANIES)
    • TABLE 392 PRODUCT FOOTPRINT ANALYSIS OF KEY PLAYERS
  • 13.7 COMPANY EVALUATION MATRIX FOR START-UPS/SMES
    • FIGURE 34 CELL ISOLATION MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022
    • 13.7.1 PROGRESSIVE COMPANIES
    • 13.7.2 STARTING BLOCKS
    • 13.7.3 RESPONSIVE COMPANIES
    • 13.7.4 DYNAMIC COMPANIES
    • 13.7.5 COMPETITIVE BENCHMARKING OF START-UPS/SMES
    • TABLE 393 CELL ISOLATION MARKET: DETAILED LIST OF KEY START-UPS/SMES
    • TABLE 394 CELL ISOLATION MARKET: COMPETITIVE BENCHMARKING OF START-UPS/SMES
  • 13.8 COMPETITIVE SCENARIO AND TRENDS
    • 13.8.1 PRODUCT LAUNCHES
    • TABLE 395 CELL ISOLATION MARKET: PRODUCT LAUNCHES, JANUARY 2020-MAY 2023
    • 13.8.2 DEALS
    • TABLE 396 CELL ISOLATION MARKET: DEALS, JANUARY 2020-MAY 2023
    • 13.8.3 OTHER DEVELOPMENTS
    • TABLE 397 CELL ISOLATION MARKET: OTHER DEVELOPMENTS, JANUARY 2020-MAY 2023

14 COMPANY PROFILES

  • 14.1 KEY PLAYERS
  • (Business Overview, Products offered, Recent Developments, MnM View)**
    • 14.1.1 THERMO FISHER SCIENTIFIC, INC.
    • TABLE 398 THERMO FISHER SCIENTIFIC, INC.: COMPANY OVERVIEW
    • FIGURE 35 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2022)
    • 14.1.2 BECTON, DICKINSON AND COMPANY (BD)
    • TABLE 399 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
    • FIGURE 36 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022)
    • 14.1.3 DANAHER CORPORATION
    • TABLE 400 DANAHER CORPORATION: COMPANY OVERVIEW
    • FIGURE 37 DANAHER CORPORATION: COMPANY SNAPSHOT (2022)
    • 14.1.4 MERCK KGAA
    • TABLE 401 MERCK KGAA: COMPANY OVERVIEW
    • FIGURE 38 MERCK KGAA: COMPANY SNAPSHOT (2022)
    • 14.1.5 TERUMO CORPORATION
    • TABLE 402 TERUMO CORPORATION: COMPANY OVERVIEW
    • FIGURE 39 TERUMO CORPORATION: COMPANY SNAPSHOT (2022)
    • 14.1.6 AGILENT TECHNOLOGIES, INC.
    • TABLE 403 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
    • FIGURE 40 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2022)
    • 14.1.7 BIO-RAD LABORATORIES, INC.
    • TABLE 404 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
    • FIGURE 41 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2022)
    • 14.1.8 CORNING INCORPORATED
    • TABLE 405 CORNING INCORPORATED: COMPANY OVERVIEW
    • FIGURE 42 CORNING INCORPORATED: COMPANY SNAPSHOT (2022)
    • 14.1.9 F. HOFFMANN-LA ROCHE LTD.
    • TABLE 406 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW
    • FIGURE 43 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2022)
    • 14.1.10 ALFA LAVAL
    • TABLE 407 ALFA LAVAL: COMPANY OVERVIEW
    • FIGURE 44 ALFA LAVAL: COMPANY SNAPSHOT (2022)
    • 14.1.11 MILTENYI BIOTEC
    • TABLE 408 MILTENYI BIOTEC: COMPANY OVERVIEW
    • 14.1.12 SARTORIUS AG
    • TABLE 409 SARTORIUS AG: COMPANY OVERVIEW
    • FIGURE 45 SARTORIUS AG: COMPANY SNAPSHOT (2022)
    • 14.1.13 STEMCELL TECHNOLOGIES
    • TABLE 410 STEMCELL TECHNOLOGIES: COMPANY OVERVIEW
    • 14.1.14 AKADEUM LIFE SCIENCES
    • TABLE 411 AKADEUM LIFE SCIENCES: COMPANY OVERVIEW
    • 14.1.15 BIO-TECHNE
    • TABLE 412 BIO-TECHNE: COMPANY OVERVIEW
    • FIGURE 46 BIO-TECHNE: COMPANY SNAPSHOT (2022)
  • 14.2 OTHER COMPANIES
    • 14.2.1 TAKARA BIO INC.
    • 14.2.2 QIAGEN
    • 14.2.3 LONZA GROUP
    • 14.2.4 PERKINELMER INC. (BIOLEGEND, INC.)
    • 14.2.5 PROMEGA CORPORATION
    • 14.2.6 PROTEINTECH GROUP, INC.
    • 14.2.7 PLURISELECT LIFE SCIENCE UG (HAFTUNGSBESCHRANKT) & CO. KG
    • 14.2.8 INVENT BIOTECHNOLOGIES, INC.
    • 14.2.9 MICAREO INC.
    • 14.2.10 MAGBIO GENOMICS
  • *Details on Business Overview, Products offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

15 APPENDIX

  • 15.1 DISCUSSION GUIDE
  • 15.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 15.3 CUSTOMIZATION OPTIONS
  • 15.4 RELATED REPORTS
  • 15.5 AUTHOR DETAILS